Budesonide 6-Beta-Hydroxy Impurity
![](https://alentris.org/wp-content/uploads/ALN-B022022-1.png)
Product Description
CAT No.
ALN-B022022
CAS No.
88411-77-2
Mol. F.
C25H34O7
Mol. Wt.
446.5
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : (6β,11β,16α)-16,17-[Butylidenebis(oxy)]-6,11,21-trihydroxypregna-1,4-diene-3,20-dione
Smiles : C[C@@]12[C@@]3(C(CO)=O)[C@@](OC(O3)CCC)([H])C[C@@]1([H])[C@]4([H])C[C@@H](O)C5=CC(C=C[C@]5(C)[C@@]4([H])[C@@H](O)C2)=O
Inchi : InChI=1S/C25H34O7/c1-4-5-21-31-20-10-15-14-9-17(28)16-8-13(27)6-7-23(16,2)22(14)18(29)11-24(15,3)25(20,32-21)19(30)12-26/h6-8,14-15,17-18,20-22,26,28-29H,4-5,9-12H2,1-3H3/t14-,15-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1
Synonym : 6β-Hydroxybudesonide (USP)
Technical Data
Reference
A validated stability indicating UHPLC method for the determination of anti-inflammatory corticosteroid budesonide epimers
By Vaddi, Lakshmi; Purushothaman, Vijayanthimala; Gowda, NagarajnFrom Journal of Pharmaceutical Sciences and Research (2020), 12(6), 848-852
Analytical method development and validation of formoterol fumarate and budesonide in pressurized meter dose inhaler form by using RP-HPLC
By Raghu, P. S. – From European Journal of Biomedical and Pharmaceutical Sciences (2018), 5(6), 1-6
Isolation and characterization of photodegradation impurity in budesonide drug product using LC-MS and NMR spectroscopy
By Bhutnar, Arun; Khapare, Sachin; Desai, Anita; Dsouza, Smitha – From American Journal of Analytical Chemistry (2017), 8(7), 449-461
RFQ